Tag Archives: Medsafe
Proposed updates to GVP Module VI and what this might mean for our clients
Good pharmacovigilance practices (GVP) are a set of measures drawn up to facilitate the performance of pharmacovigilance in the European Union (EU). GVP apply to marketing-authorisation holders, the European Medicines Agency and medicines regulatory authorities in EU Member States. The … Continue reading
Posted in Life Sciences Industry, Pharmacovigilance, TGA
Tagged European Medicines Agency, GVP, Medsafe, TGA
Comments Off on Proposed updates to GVP Module VI and what this might mean for our clients
New Zealand Pharmacovigilance Guidelines Edition 2, effective in the New Year
In April this year, Medsafe released the new draft guidelines for pharmacovigilance (PV) in New Zealand. Interested parties were invited to provide comment and Medsafe provided feedback on these on their website. Part 8 of the Guideline of Therapeutic Products … Continue reading
Posted in Life Sciences Industry, Medical Services
Tagged Medsafe, NZ, Pharmacovigilance
Comments Off on New Zealand Pharmacovigilance Guidelines Edition 2, effective in the New Year
